Subsequent Events (Details Textual) - Subsequent Event [Member] - Jade Therapeutics, Inc [Member] |
Mar. 07, 2016
USD ($)
$ / shares
shares
|
---|---|
Subsequent Event [Line Items] | |
Shares Issued, Price Per Share | $ / shares | $ 3.80 |
Business Acquisition, Name of Acquired Entity | Jade Therapeutics, Inc. |
Business Acquisition, Description of Shares Issued | common stock, 90% of which were issued at the closing and 10% of which will be held back for 18 months to satisfy post-closing adjustments or indemnification obligations. |
Business Combination, Consideration Transferred, Liabilities Incurred | $ 300,000 |
Stock Issued During Period, Shares, Acquisitions | shares | 765,728 |
Payments to Acquire Businesses, Gross | $ 2,164,451 |
X | ||||||||||
- Definition It represents the business acquisition description of shares issued. No definition available.
|
X | ||||||||||
- Definition Name of the acquired entity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Per share or per unit amount of equity securities issued. No definition available.
|
X | ||||||||||
- Definition Number of shares of stock issued during the period pursuant to acquisitions. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|